Tipirneni Praveen P.
SEC insider (Form 3/4/5 filer). CIK 0001779978. Director at BridgeBio Oncology Therapeutics, Inc. (BBOT) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in WATERTOWN, MA.
Companies Tipirneni Praveen P. has filed insider reports for
- BridgeBio Oncology Therapeutics, Inc. (BBOT): Director
- Tectonic Therapeutic, Inc. (TECX): Director
Tipirneni Praveen P.
CIK: 0001779978
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 16, 2026BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31.7K shares- - Jun 9, 2026TECX
Tectonic Therapeutic, Inc.
AwardDirectStock Option (Right to Buy)
10.2K shares- - Aug 26, 2025BBOT
BridgeBio Oncology Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
52.3K shares- - Jun 9, 2025TECX
Tectonic Therapeutic, Inc.
AwardDirectStock Option (Right to Buy)
10.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  BBOT BridgeBio Oncology Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,675 | - | - | Direct |
| Jun 9, 2026 |  TECX Tectonic Therapeutic, Inc. | Award Stock Option (Right to Buy) | 10,200 | - | - | Direct |
| Aug 26, 2025 | BBOT BridgeBio Oncology Therapeutics, Inc. | Award Stock Option (Right to Buy) | 52,269 | - | - | Direct |
| Jun 9, 2025 | TECX Tectonic Therapeutic, Inc. | Award Stock Option (Right to Buy) | 10,200 | - | - | Direct |
1-4 of 4 transactions